Furthermore, a murine model, involving Erbb4 deletion has demonstrated the emergence of various characteristics seen in PCOS patients, specifically disrupted ovulatory cycles with oligomenorrhoea, obesity and impaired oocyte development. Here, ERBB4 is linked to obesity disorder.